Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT<sub>1</sub> receptor expression as measured with PET imaging - Fig 2 Basma Ismail Rob A. deKemp Etienne Croteau Tayebeh Hadizad Kevin D. Burns Rob S. Beanlands Jean N. DaSilva 10.1371/journal.pone.0177451.g002 https://plos.figshare.com/articles/figure/Treatment_with_enalapril_and_not_diltiazem_ameliorated_progression_of_chronic_kidney_disease_in_rats_and_normalized_renal_AT_sub_1_sub_receptor_expression_as_measured_with_PET_imaging_-_Fig_2/5025449 <p><b>Body weight data obtained weekly over 10 weeks (A), terminal left kidney weight for sham (N = 8), Nx (N = 8), NxE (N = 6) and NxD (N = 8) (B) and heart weight for sham (N = 8), Nx (N = 9), NxE (N = 9) and NxD (N = 8) (C) normalized to body weight at 18–20 weeks post-surgery.</b> Data are presented as mean±SD. * <i>p</i><0.05 vs sham, <sup>$</sup> <i>p</i><0.05 vs Nx, <sup>#</sup> <i>p</i><0.05 vs NxE (p<0.05).</p> 2017-05-19 17:28:13 CKD blood flow calcium channel blockers 1 R expression kidney angiotensin II diltiazem ameliorated progression positron emission tomography 1 R levels 1 receptor expression Nx 1 R changes PET imaging ACE inhibitors kidney disease enalapril systolic blood pressure